Quinapril/Hydrochlorothiazide Tablet — FDA Drug Shortage
The FDA lists a drug shortage record for Quinapril/Hydrochlorothiazide Tablet (tablet) from Aurobindo Pharma USA with status Current. The shortage was first posted on Jan 19, 2023. Reported reason: Discontinuation of the manufacture of the drug
Shortage details
- Status
- Current
- Company
- Aurobindo Pharma USA
- Package NDC
- 65862-161-90
- Dosage Form
- Tablet
- Presentation
- Quinapril Hydrochloride And Hydrochlorothiazide, Tablet, 12.5 mg; 10 mg (NDC 65862-161-90)
- Initial Posting
- Jan 19, 2023
Reason
Discontinuation of the manufacture of the drug